DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0090-9556/04/3206-661-665$20.00
DMD 32:661-665, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frederiksen, H.
Right arrow Articles by Frandsen, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frederiksen, H.
Right arrow Articles by Frandsen, H.

IDENTIFICATION OF METABOLITES IN URINE AND FECES FROM RATS DOSED WITH THE HETEROCYCLIC AMINE, 2-AMINO-3-METHYL-9H-PYRIDO[2,3-b]INDOLE (MeA{alpha}C)

H. Frederiksen, and H. Frandsen

Institute of Food Safety and Nutrition, Danish Veterinary and Food Administration, Søborg, Denmark

2-Amino-3-methyl-9H-pyrido[2,3-b]indole (MeA{alpha}C) is a proximate mutagenic and carcinogenic heterocyclic amine formed during ordinary cooking. In model systems, MeA{alpha}C can be formed by pyrolyses of either tryptophan or proteins of animal or vegetable origin. In the present study, the in vivo metabolism of MeA{alpha}C in rats was investigated. Rats were dosed with tritium-labeled MeA{alpha}C, and urine and feces were collected over 3 days. The metabolites of MeA{alpha}C were identified by high performance liquid chromatography-mass spectrometry and quantified by liquid scintillation counting. Conjugated metabolites were characterized by enzymatic hydrolyzes with ß-glucuronidase or arylsulfatase. The data showed that the metabolic pattern of MeA{alpha}C was similar in all rats. About 65% of the dose was excreted in urine and feces, and the major amount of MeA{alpha}C-metabolites was excreted during the first 24 h. Thirty-four percent of the dose was found in the rat urine samples collected to 24 h. In addition to unmetabolized MeA{alpha}C and two phase I metabolites, 6-OH-MeA{alpha}C and 7-OH-MeA{alpha}C, the following conjugated metabolites were identified: MeA{alpha}C-N2-glucuronide, A{alpha}C-3-CH2O-glucuronide, 3-carboxy-A{alpha}C and 3-carboxy-A{alpha}C-glucuronide, and sulfate and glucuronide conjugates of 6-OH-MeA{alpha}C and 7-OH-MeA{alpha}C. Also, a large amount of a rather unstable compound proposed to be of MeA{alpha}C-N1-glucuronide was found. About 21% of the dose was excreted in feces during the first 24 h, and MeA{alpha}C and 7-OH-MeA{alpha}C were the only compounds identified in feces. Any activated metabolites of MeA{alpha}C were not detected in rat urine or feces.


Address correspondence to: Henrik Frandsen, Institute of Food Safety and Nutrition, Danish Veterinary and Food Administration, Mørkhøj Bygade 19, DK 2860 Søborg, Denmark. E-mail: hf{at}fdir.dk







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.